
LACWEL-B SACHET Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
LACWEL-B SACHET
Lactic Acid Bacillus 150 Million
LACWEL-B SACHET (Lactic Acid Bacillus 150 Million) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in LACWEL-B SACHET deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C in a dry place. Protect from moisture and direct sunlight.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
LACWEL-B SACHET features Lactic Acid Bacillus 150 Million prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Endorsed by attending medical offic for LACWEL-B SACHET
LACWEL-B SACHET has been endorsed by attending medical officers for dependable recovery, offering predictable therapeutic action that doctors in our territory rely upon daily. Sturdy outer cartons and individual pack serialization facilitate seamless inventory scanning. Continues to be a key prescription driver in our PCD pharma franchise portfolio.
Questions Regarding LACWEL-B SACHET
What is the therapeutic indication and composition of LACWEL-B SACHET?
LACWEL-B SACHET contains Lactic Acid Bacillus 150 Million indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for LACWEL-B SACHET?
LACWEL-B SACHET is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for LACWEL-B SACHET?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for LACWEL-B SACHET along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
LACWEL-B SACHET is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.





